SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BiGx who wrote (6606)1/2/1999 5:10:00 PM
From: BigKNY3  Read Replies (1) | Respond to of 9523
 
Announcing the 1999 Pharmer Portfolio Challenge

Here is the first PFEr Challenge for 1999.

All PFErs, Pharmers, bulls, bears, longs, shorts and lurkers are welcome to participate.

Last year, the first Portfolio Challenge with 35 entrants provided real insight into various Big Pharma investing strategies.

Have PFun!

BigKNY3

Da Challenge:

On January 2, 1999, you receive a mythical $10,000 to invest only in the 13 stocks listed in the Big Pharma Report (see list below).

Using percentages, allocate these monies in cash and long positions and short positions in the 13 Big Pharma stocks. Your percentage must add up to 100%. You have until 11:59 pm on Sunday, January 10, 1999 to submit your portfolio to your mythical broker- Mr. Peabody- on the Pfizer Board on either AOL's Motley Fool or Silicon Investor.

Your portfolio will be evaluated based on purchase prices using the closes on December 31, 1998 and selling prices based on the closes on December 31, 1999.

Please also provide a sentence or two explaining your Big Pharma investing strategy for 1999.

..................... . % of Long/
Pharma Ticker Total Short
Cash
Abbott ABT
Amer AHP
Amgen AMGN
Bristol BMY
Glaxo GLX
J&J JNJ
Lilly LLY
Merck MRK
Pfizer PFE
Pharma PNU
Smith SBH
Scher SGP
Warner WLA .
............ 100%

Explanation of 1999 Big Pharma Strategy:

________________________________________________

Example:

In this portfolio, 25% is allocated to cash, 50% to SBH (long), and 25% to SGP (short).

......................... . % of Long/
Pharma Ticker Total Short
Cash 25%
Abbott ABT
Amer AHP
Amgen AMGN
Bristol BMY
Glaxo GLX
J&J JNJ
Lilly LLY
Merck MRK
Pfizer PFE
Pharma PNU
Smith SBH 50% Long
Scher SGP 25% Short
Warner WLA .
............. 100%

Explanation of 1999 Big Pharma Strategy: SBH ready to take off, SGP to decline due to concerns related to Claritin patent.